Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Gac. méd. Méx ; 155(5): 423-429, Sep.-Oct. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1286538

RESUMEN

Introduction: Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective vaccination prevents the occurrence of serious cases and decreases mortality. Objective: To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico. Method: Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used. Results: From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir. Conclusions: Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Vacunas contra la Influenza/administración & dosificación , Inmunización/mortalidad , Gripe Humana/mortalidad , Antivirales/uso terapéutico , Factores de Tiempo , Comorbilidad , Vigilancia de la Población , Estudios Transversales , Inmunización/estadística & datos numéricos , Gripe Humana/virología , Subtipo H1N1 del Virus de la Influenza A , México/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA